Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evangelia Emmanouilidou

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Brain Pathology (Zurich, Switzerland)|March 5, 2016
Exocytosis and Spreading of Normal and Aberrant α-SynucleinEvangelia Emmanouilidou, Kostas Vekrellis
Neurobiology of Aging|August 22, 2008
Cell-produced alpha-synuclein oligomers are targeted to, and impair, the 26S proteasomeEvangelia Emmanouilidou, Leonidas Stefanis, Kostas Vekrellis
Frontiers in Molecular Neuroscience|October 26, 2019
Voltage-Gated Calcium Channels and α-Synuclein: Implications in Parkinson's DiseaseEmmanouela Leandrou, Evangelia Emmanouilidou, Kostas Vekrellis
Journal of Neurochemistry|May 30, 2009
Inducible over-expression of wild type alpha-synuclein in human neuronal cells leads to caspase-dependent non-apoptotic deathKostas Vekrellis, Maria Xilouri, Evangelia Emmanouilidou, et al.
NPJ Parkinson'S Disease|September 26, 2025
N-type Ca<sup>2+</sup> channels mediate the stimuli-dependent α-synuclein secretion in mouse striatumEmmanouela Leandrou, Ioanna Chalatsa, Kostas Vekrellis, et al.
Cold Spring Harbor Perspectives in Medicine|September 30, 2024
α-Synuclein in Parkinson's Disease: 12 Years LaterKostas Vekrellis, Evangelia Emmanouilidou, Maria Xilouri, et al.
Plos One|November 28, 2013
The diagnostic value of CSF α-synuclein in the differential diagnosis of dementia with Lewy bodies vs. normal subjects and patients with Alzheimer's diseaseElisabeth Kapaki, George P Paraskevas, Evangelia Emmanouilidou, et al.
Parkinsonism & Related Disorders|February 12, 2025
Aggregated α-synuclein in erythrocytes as a potential biomarker for idiopathic Parkinson's DiseaseKonstantina Dimoula, Nikolaos Papagiannakis, Matina Maniati, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 9, 2020
High discriminatory ability of peripheral and CFSF biomarkers in Lewy body diseasesAnastasia Bougea, Leonidas Stefanis, Evangelia Emmanouilidou, et al.
The Lancet. Neurology|October 22, 2011
Pathological roles of α-synuclein in neurological disordersKostas Vekrellis, Maria Xilouri, Evangelia Emmanouilidou, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Brain Pathology (Zurich, Switzerland)|March 5, 2016
Exocytosis and Spreading of Normal and Aberrant α-SynucleinEvangelia Emmanouilidou, Kostas Vekrellis
Neurobiology of Aging|August 22, 2008
Cell-produced alpha-synuclein oligomers are targeted to, and impair, the 26S proteasomeEvangelia Emmanouilidou, Leonidas Stefanis, Kostas Vekrellis
Frontiers in Molecular Neuroscience|October 26, 2019
Voltage-Gated Calcium Channels and α-Synuclein: Implications in Parkinson's DiseaseEmmanouela Leandrou, Evangelia Emmanouilidou, Kostas Vekrellis
Journal of Neurochemistry|May 30, 2009
Inducible over-expression of wild type alpha-synuclein in human neuronal cells leads to caspase-dependent non-apoptotic deathKostas Vekrellis, Maria Xilouri, Evangelia Emmanouilidou, et al.
NPJ Parkinson'S Disease|September 26, 2025
N-type Ca<sup>2+</sup> channels mediate the stimuli-dependent α-synuclein secretion in mouse striatumEmmanouela Leandrou, Ioanna Chalatsa, Kostas Vekrellis, et al.
Cold Spring Harbor Perspectives in Medicine|September 30, 2024
α-Synuclein in Parkinson's Disease: 12 Years LaterKostas Vekrellis, Evangelia Emmanouilidou, Maria Xilouri, et al.
Plos One|November 28, 2013
The diagnostic value of CSF α-synuclein in the differential diagnosis of dementia with Lewy bodies vs. normal subjects and patients with Alzheimer's diseaseElisabeth Kapaki, George P Paraskevas, Evangelia Emmanouilidou, et al.
Parkinsonism & Related Disorders|February 12, 2025
Aggregated α-synuclein in erythrocytes as a potential biomarker for idiopathic Parkinson's DiseaseKonstantina Dimoula, Nikolaos Papagiannakis, Matina Maniati, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 9, 2020
High discriminatory ability of peripheral and CFSF biomarkers in Lewy body diseasesAnastasia Bougea, Leonidas Stefanis, Evangelia Emmanouilidou, et al.
The Lancet. Neurology|October 22, 2011
Pathological roles of α-synuclein in neurological disordersKostas Vekrellis, Maria Xilouri, Evangelia Emmanouilidou, et al.
Pageof 4